Long-Term Impact of Hepatitis C Virus Eradication on Liver Stiffness in Egyptian Patients
Autor: | Talaat Zakareya, Mostafa Elhelbawy, Hassan Elzohry, Mohamed Eltabbakh, Mohamed Deif, Mohamed Abbasy |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: | |
Zdroj: | Canadian Journal of Gastroenterology and Hepatology, Vol 2021 (2021) |
Druh dokumentu: | article |
ISSN: | 2291-2789 2291-2797 |
DOI: | 10.1155/2021/4961919 |
Popis: | Background/Objectives. Liver fibrosis is the inevitable end result of chronic hepatitis C (HCV) infection and is responsible for almost all liver-related complications. After the big advancement in therapeutics of HCV, liver fibrosis would expectedly improve after viral clearance. Many studies showed significant improvement of liver fibrosis shortly after successful treatment with direct acting antiviral agents (DAAs); however, the long-term changes have been scarcely addressed in the literature. We aimed to trace dynamical changes in liver stiffness 1, 3, and 5 years after HCV eradication. Methods. Liver stiffness measurements (LSM) have been serially assessed 1, 3, and 5 years after HCV clearance in 655 patients who have been treated with DAAs. Results. The mean age was 51.44 ± 10 years. 73% of patients were males. 48% were cirrhotics. In noncirrhotics, the mean LSM was significantly decreased from 8.29 ± 2.3 kPa to 4.03 ± 1.0 kPa p |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |